Manuscripts
January 10, 2023
Challenges to using big data in cancer
Cancer Research
Sweeney SM et al
August 10, 2022
Incidence of SARS-CoV-2 and subsequent mortality in a multi-site cohort of patients with cancer in the CancerLinQ Discovery database
JCO Oncology Practice
Ray E et al
June 3, 2022
Retrospective analysis of real-world management of EGFR-mutated advanced NSCLC, after first-line EGFR-TKI treatment: US treatment patterns, attrition, and survival data
Drugs - Real World Outcomes
Nieva J et al
May 1, 2022
Reaching beyond maximum grade: Progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies
The Lancet Haematology
Thanarajasingam G et al
April 28, 2022
Cancer registry data linkage of electronic health record data from ASCO's CancerLinQ: Evaluation of advantages, limitations, and lessons learned
JCO Clinical Cancer Informatics
Charlton M et al
February 22, 2022
Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a CancerLinQ study
Breast Cancer Research and Treatment
Miller RS et al
January 7, 2022
Quantitating and assessing interoperability between electronic health records
Journal of the American Medical Informatics Association
Bernstam E et al
January 5, 2022
The Chasm between Cancer Quality Measures and EHR Data Quality
JCO Clinical Cancer Informatics
Schorer A et al
October 18, 2021
The Friends of Cancer Research Real World Data (RWD) Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies
Clinical Pharmacology & Therapeutics
Rivera D et al
Abstracts
June 2, 2023
Pitfalls with analyses of real-world data: A look at ASCO’s CancerLinQ Discovery Multiple Myeloma dataset
ASCO Annual Meeting 2023
Shou K J et al
June 2, 2023
Treatment outcomes in patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC) harboring MET amplification as a secondary oncogenic driver
ASCO Annual Meeting 2023
Ryder A et al
June 2, 2023
Biomarker testing and treatment patterns in US patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC) harboring MET amplification
ASCO Annual Meeting 2023
Ryder A et al
June 2, 2023
Assessment of electronic health record (EHR)-based machine learning (ML) in predicting risk of brain metastasis among patients with early-stage non-small-cell lung cancer (eNSCLC)
ASCO Annual Meeting 2023
Honarvar H et al
June 2, 2023
Electronic health record (EHR)-based machine learning (ML) to predict disease recurrence after surgical resection of early-stage non-small cell lung cancer (eNSCLC)
ASCO Annual Meeting 2023
Pisano S et al
June 2, 2023
Identification of biomarkers for early progression in muscle invasive bladder cancer (MIBC) using real-world data
ASCO Annual Meeting 2023
Singh N et al
June 2, 2023
Evaluating clinical trial inclusion/exclusion criteria from claims using generative artificial intelligence
ASCO Annual Meeting 2023
Mueller J et al
June 2, 2023
Development of natural language processing (NLP) models for extracting key features from unstructured notes to create real-world data (RWD) assets for clinical research at scale
ASCO Annual Meeting 2023
Agrawal S et al
June 2, 2023
Enhancement in line of therapy (LoT) derivation from real-world data (RWD) from electronic health records (EHR) via integration of medical claims data
ASCO Annual Meeting 2023
Agrawal S et al
